A Phase 2b, Multicenter, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of Short-Course Antimicrobial Therapy for Young Children With Acute Otitis Media (AOM) and Impact on Antimicrobial Resistance
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Amoxicillin/clavulanic acid (Primary)
- Indications Bacterial infections; Otitis media
- Focus Therapeutic Use
- 06 Oct 2017 Biomarkers information updated
- 25 Jan 2012 New trial record